Pelvic recurrence of an ovarian seromucinous borderline tumor detected by vaginal cytology: A case report and review of the literature-Reference-Cited by-同舟云学术

Pelvic recurrence of an ovarian seromucinous borderline tumor detected by vaginal cytology: A case report and review of the literature

Published:2016-07-06 Issue:11 Volume:44 Page:912-916
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagn. Cytopathol.

Author:

Hayashi Hironori¹,Taniguchi Shuichi¹,Kurihara Shuichi¹,Hachisuga Kazuhisa¹,Fukuda Saori²,Inada Chifumi²,Shimao Yoshiya²,Marutsuka Kousuke²,Shimamoto Tomihiro¹

Affiliation:

1. Department of Obstetrics and Gynecology; Miyazaki Prefectural Hospital; Kitatakamatsucho 5-30, Miyazaki Miyazaki 880-8510 Japan

2. Department of Pathology; Miyazaki Prefectural Hospital; Kitatakamatsucho 5-30, Miyazaki Miyazaki 880-8510 Japan

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference18 articles.

1. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis;Rutgers;Cancer,1988

2. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis;Rutgers;Cancer,1988

3. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas;Shappell;Am J Surg Pathol,2002

4. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation;Kim;Histopathology,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of seromucinous borderline tumor with squamous differentiation suspected intraoperatively by a combination of ascitic fluid and imprint cytology;The Journal of the Japanese Society of Clinical Cytology;2024

2. Practical Approach to the Evaluation of Malignant Peritoneal Fluids in the Setting of Gynecologic Neoplasms;Acta Cytologica;2022-12-26

3. Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy;Gynecologic Oncology Reports;2021-02

4. Cytological Appearances of Ovarian Seromucinous Borderline Tumor in Ascites: Presentation of 2 Cases;Acta Cytologica;2021